Coloplast: Went 'BUY' A Bit Early
Coloplast is rebased to a 20x P/E with a new price target of 490 DKK, reflecting a more realistic va…

Annual Recurring Revenue (ARR) growth and net revenue retention rates - key indicators of subscription business health
New customer wins in target verticals (financial services, healthcare) and competitive displacement of legacy systems
Product innovation announcements around generative AI integration and conversational AI capabilities
Profitability inflection - movement from breakeven/low single-digit margins toward SaaS peer benchmarks (15-20% operating margins)
moderate - Enterprise software spending correlates with corporate IT budgets, which compress during recessions as companies delay discretionary technology investments. However, customer service automation can be positioned as cost-saving during downturns (reducing contact center headcount), providing some defensive characteristics. Financial services and healthcare verticals show more resilient spending than cyclical industries.
Rising interest rates negatively impact eGain through multiple channels: (1) higher discount rates compress valuation multiples for unprofitable/low-margin SaaS companies, (2) enterprise customers face higher cost of capital, potentially extending sales cycles or reducing deal sizes, (3) competition for investor capital intensifies as bonds become more attractive versus speculative growth stocks. The company's positive cash flow provides some insulation versus cash-burning peers.
Commoditization of customer engagement software as hyperscalers (Microsoft, Google, Amazon) embed AI capabilities into broader cloud platforms, potentially eroding standalone vendor pricing power
Rapid advancement in generative AI (ChatGPT, Claude) enabling enterprises to build custom solutions in-house rather than purchasing third-party platforms, particularly for knowledge management use cases
Consolidation pressure as larger CX platform vendors (Salesforce, Oracle, SAP) acquire point solutions to create integrated suites, making standalone vendors less competitive in enterprise deals
value - The stock attracts value-oriented investors given low valuation multiples (3.0x P/S, 17.1x EV/EBITDA) relative to high-growth SaaS peers, combined with positive cash flow and strong balance sheet. The 86% one-year return suggests momentum investors have recently entered following profitability inflection (36.5% net margin, 314% net income growth). However, negative revenue growth (-4.7%) limits appeal to pure growth investors. Small market cap ($300M) attracts microcap specialists and potential M&A arbitrage players.
Trend
-35.1% vs SMA 50 · -9.2% vs SMA 200
Momentum
Heavy distribution on elevated volume — institutions appear to be exiting. Squeeze setups unlikely while selling pressure persists.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2023 | $97.1M $96.9M–$97.3M | — | $0.20 | — | ±2% | Low1 |
FY2024 | $91.7M $90.0M–$93.6M | ▼ -5.6% | $0.34 | ▲ +71.8% | ±3% | Low1 |
FY2025 | $88.2M $86.6M–$90.0M | ▼ -3.8% | $0.18 | ▼ -44.8% | ±3% | Low1 |
Coloplast is rebased to a 20x P/E with a new price target of 490 DKK, reflecting a more realistic va…

eGain customer engagement platform automates digital-first, omnichannel experiences across all touch points. Powered by AI, machine learning, knowledge, and analytics, its top-rated software optimizes customer journeys with virtual assistance, messaging hub, and desktop to serve customers, reduce cost, and improve compliance.
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
EGAN◀ | $6.49 | -3.57% | $178M | 4.6 | -471.1% | 3647.4% | 1500 |
| $225.32 | -4.42% | $5.5T | 45.6 | +6547.4% | 5560.3% | 1502 | |
| $300.23 | +0.68% | $4.4T | 36.0 | +642.6% | 2691.5% | 1482 | |
| $421.92 | +3.05% | $3.1T | 25.0 | +1493.2% | 3614.6% | 1460 | |
| $425.19 | -3.32% | $2.0T | 80.7 | +2387.4% | 3619.8% | 1500 | |
| $724.66 | -6.62% | $817.2B | 33.8 | +4885.1% | 2284.5% | 1532 | |
| $424.10 | -5.69% | $691.5B | 138.6 | +3433.8% | 1251.5% | 1516 | |
| Sector avg | — | -2.84% | — | 52.0 | +2702.6% | 3238.5% | 1499 |